CINTAS CORP (CTAS) Fundamental Analysis & Valuation

NASDAQ:CTAS • US1729081059

Current stock price

174.34 USD
+2.3 (+1.34%)
At close:
174.57 USD
+0.23 (+0.13%)
After Hours:

This CTAS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

10

1. CTAS Profitability Analysis

1.1 Basic Checks

  • In the past year CTAS was profitable.
  • CTAS had a positive operating cash flow in the past year.
  • Each year in the past 5 years CTAS has been profitable.
  • CTAS had a positive operating cash flow in each of the past 5 years.
CTAS Yearly Net Income VS EBIT VS OCF VS FCFCTAS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

1.2 Ratios

  • CTAS's Return On Assets of 18.67% is amongst the best of the industry. CTAS outperforms 98.77% of its industry peers.
  • The Return On Equity of CTAS (42.46%) is better than 96.30% of its industry peers.
  • With an excellent Return On Invested Capital value of 24.58%, CTAS belongs to the best of the industry, outperforming 98.77% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for CTAS is significantly above the industry average of 10.27%.
  • The last Return On Invested Capital (24.58%) for CTAS is above the 3 year average (21.68%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 18.67%
ROE 42.46%
ROIC 24.58%
ROA(3y)17.06%
ROA(5y)15.93%
ROE(3y)36.52%
ROE(5y)35.33%
ROIC(3y)21.68%
ROIC(5y)20.31%
CTAS Yearly ROA, ROE, ROICCTAS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • The Profit Margin of CTAS (17.52%) is better than 97.53% of its industry peers.
  • In the last couple of years the Profit Margin of CTAS has grown nicely.
  • The Operating Margin of CTAS (22.98%) is better than 97.53% of its industry peers.
  • CTAS's Operating Margin has improved in the last couple of years.
  • The Gross Margin of CTAS (50.25%) is better than 86.42% of its industry peers.
  • CTAS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 22.98%
PM (TTM) 17.52%
GM 50.25%
OM growth 3Y3.91%
OM growth 5Y6.07%
PM growth 3Y3.71%
PM growth 5Y7.35%
GM growth 3Y2.66%
GM growth 5Y1.86%
CTAS Yearly Profit, Operating, Gross MarginsCTAS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

8

2. CTAS Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CTAS is creating value.
  • Compared to 1 year ago, CTAS has less shares outstanding
  • The number of shares outstanding for CTAS has been reduced compared to 5 years ago.
  • Compared to 1 year ago, CTAS has an improved debt to assets ratio.
CTAS Yearly Shares OutstandingCTAS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
CTAS Yearly Total Debt VS Total AssetsCTAS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

  • CTAS has an Altman-Z score of 11.11. This indicates that CTAS is financially healthy and has little risk of bankruptcy at the moment.
  • CTAS has a better Altman-Z score (11.11) than 92.59% of its industry peers.
  • CTAS has a debt to FCF ratio of 1.67. This is a very positive value and a sign of high solvency as it would only need 1.67 years to pay back of all of its debts.
  • CTAS's Debt to FCF ratio of 1.67 is amongst the best of the industry. CTAS outperforms 85.19% of its industry peers.
  • CTAS has a Debt/Equity ratio of 0.54. This is a neutral value indicating CTAS is somewhat dependend on debt financing.
  • The Debt to Equity ratio of CTAS (0.54) is comparable to the rest of the industry.
  • Even though the debt/equity ratio score it not favorable for CTAS, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF 1.67
Altman-Z 11.11
ROIC/WACC2.74
WACC8.96%
CTAS Yearly LT Debt VS Equity VS FCFCTAS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.3 Liquidity

  • CTAS has a Current Ratio of 1.71. This is a normal value and indicates that CTAS is financially healthy and should not expect problems in meeting its short term obligations.
  • CTAS has a Current ratio of 1.71. This is in the better half of the industry: CTAS outperforms 65.43% of its industry peers.
  • A Quick Ratio of 1.49 indicates that CTAS should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.49, CTAS is in line with its industry, outperforming 59.26% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.71
Quick Ratio 1.49
CTAS Yearly Current Assets VS Current LiabilitesCTAS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

5

3. CTAS Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 9.79% over the past year.
  • The Earnings Per Share has been growing by 16.84% on average over the past years. This is quite good.
  • The Revenue has been growing slightly by 7.75% in the past year.
  • The Revenue has been growing slightly by 7.85% on average over the past years.
EPS 1Y (TTM)9.79%
EPS 3Y15.77%
EPS 5Y16.84%
EPS Q2Q%9.73%
Revenue 1Y (TTM)7.75%
Revenue growth 3Y9.6%
Revenue growth 5Y7.85%
Sales Q2Q%8.9%

3.2 Future

  • The Earnings Per Share is expected to grow by 11.23% on average over the next years. This is quite good.
  • CTAS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.52% yearly.
EPS Next Y12.75%
EPS Next 2Y11.88%
EPS Next 3Y11.47%
EPS Next 5Y11.23%
Revenue Next Year8.99%
Revenue Next 2Y8.25%
Revenue Next 3Y8.38%
Revenue Next 5Y7.52%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CTAS Yearly Revenue VS EstimatesCTAS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B
CTAS Yearly EPS VS EstimatesCTAS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

2

4. CTAS Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 36.78, the valuation of CTAS can be described as expensive.
  • CTAS's Price/Earnings ratio is in line with the industry average.
  • When comparing the Price/Earnings ratio of CTAS to the average of the S&P500 Index (26.17), we can say CTAS is valued slightly more expensively.
  • CTAS is valuated quite expensively with a Price/Forward Earnings ratio of 31.59.
  • CTAS's Price/Forward Earnings is on the same level as the industry average.
  • When comparing the Price/Forward Earnings ratio of CTAS to the average of the S&P500 Index (23.05), we can say CTAS is valued slightly more expensively.
Industry RankSector Rank
PE 36.78
Fwd PE 31.59
CTAS Price Earnings VS Forward Price EarningsCTAS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CTAS is on the same level as its industry peers.
  • CTAS's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 39.03
EV/EBITDA 24.23
CTAS Per share dataCTAS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The excellent profitability rating of CTAS may justify a higher PE ratio.
PEG (NY)2.88
PEG (5Y)2.18
EPS Next 2Y11.88%
EPS Next 3Y11.47%

5

5. CTAS Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 1.09%, CTAS has a reasonable but not impressive dividend return.
  • CTAS's Dividend Yield is a higher than the industry average which is at 0.86.
  • With a Dividend Yield of 1.09, CTAS pays less dividend than the S&P500 average, which is at 1.89.
Industry RankSector Rank
Dividend Yield 1.09%

5.2 History

  • On average, the dividend of CTAS grows each year by 18.49%, which is quite nice.
  • CTAS has been paying a dividend for at least 10 years, so it has a reliable track record.
  • CTAS has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)18.49%
Div Incr Years4
Div Non Decr Years4
CTAS Yearly Dividends per shareCTAS Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • 34.69% of the earnings are spent on dividend by CTAS. This is a low number and sustainable payout ratio.
  • CTAS's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP34.69%
EPS Next 2Y11.88%
EPS Next 3Y11.47%
CTAS Yearly Income VS Free CF VS DividendCTAS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
CTAS Dividend Payout.CTAS Dividend Payout, showing the Payout Ratio.CTAS Dividend Payout.PayoutRetained Earnings

CTAS Fundamentals: All Metrics, Ratios and Statistics

CINTAS CORP

NASDAQ:CTAS (4/2/2026, 8:17:05 PM)

After market: 174.57 +0.23 (+0.13%)

174.34

+2.3 (+1.34%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)03-25
Earnings (Next)07-15
Inst Owners67.62%
Inst Owner Change0%
Ins Owners1.64%
Ins Owner Change-0.1%
Market Cap69.50B
Revenue(TTM)10.34B
Net Income(TTM)1.89B
Analysts71.11
Price Target224.06 (28.52%)
Short Float %2.8%
Short Ratio4.23
Dividend
Industry RankSector Rank
Dividend Yield 1.09%
Yearly Dividend1.51
Dividend Growth(5Y)18.49%
DP34.69%
Div Incr Years4
Div Non Decr Years4
Ex-Date02-13
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.88%
Min EPS beat(2)-0.91%
Max EPS beat(2)-0.85%
EPS beat(4)1
Avg EPS beat(4)0.77%
Min EPS beat(4)-0.91%
Max EPS beat(4)4.93%
EPS beat(8)5
Avg EPS beat(8)3.74%
EPS beat(12)8
Avg EPS beat(12)2.8%
EPS beat(16)12
Avg EPS beat(16)3.25%
Revenue beat(2)0
Avg Revenue beat(2)-0.99%
Min Revenue beat(2)-1.23%
Max Revenue beat(2)-0.74%
Revenue beat(4)0
Avg Revenue beat(4)-0.97%
Min Revenue beat(4)-1.5%
Max Revenue beat(4)-0.39%
Revenue beat(8)0
Avg Revenue beat(8)-1.32%
Revenue beat(12)0
Avg Revenue beat(12)-1.13%
Revenue beat(16)4
Avg Revenue beat(16)-0.57%
PT rev (1m)0.31%
PT rev (3m)1.53%
EPS NQ rev (1m)0.5%
EPS NQ rev (3m)0.3%
EPS NY rev (1m)0%
EPS NY rev (3m)0.03%
Revenue NQ rev (1m)0.14%
Revenue NQ rev (3m)0.17%
Revenue NY rev (1m)0.23%
Revenue NY rev (3m)0.28%
Valuation
Industry RankSector Rank
PE 36.78
Fwd PE 31.59
P/S 6.44
P/FCF 39.03
P/OCF 31.54
P/B 15.6
P/tB 103.1
EV/EBITDA 24.23
EPS(TTM)4.74
EY2.72%
EPS(NY)5.52
Fwd EY3.17%
FCF(TTM)4.47
FCFY2.56%
OCF(TTM)5.53
OCFY3.17%
SpS27.08
BVpS11.18
TBVpS1.69
PEG (NY)2.88
PEG (5Y)2.18
Graham Number34.52
Profitability
Industry RankSector Rank
ROA 18.67%
ROE 42.46%
ROCE 30.79%
ROIC 24.58%
ROICexc 25.21%
ROICexgc 48.61%
OM 22.98%
PM (TTM) 17.52%
GM 50.25%
FCFM 16.5%
ROA(3y)17.06%
ROA(5y)15.93%
ROE(3y)36.52%
ROE(5y)35.33%
ROIC(3y)21.68%
ROIC(5y)20.31%
ROICexc(3y)22.42%
ROICexc(5y)21.1%
ROICexgc(3y)45.31%
ROICexgc(5y)44.66%
ROCE(3y)27.16%
ROCE(5y)25.44%
ROICexgc growth 3Y4.19%
ROICexgc growth 5Y9.87%
ROICexc growth 3Y7.31%
ROICexc growth 5Y10.45%
OM growth 3Y3.91%
OM growth 5Y6.07%
PM growth 3Y3.71%
PM growth 5Y7.35%
GM growth 3Y2.66%
GM growth 5Y1.86%
F-Score8
Asset Turnover1.07
Health
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF 1.67
Debt/EBITDA 0.81
Cap/Depr 84.15%
Cap/Sales 3.92%
Interest Coverage 250
Cash Conversion 73.86%
Profit Quality 94.13%
Current Ratio 1.71
Quick Ratio 1.49
Altman-Z 11.11
F-Score8
WACC8.96%
ROIC/WACC2.74
Cap/Depr(3y)83.77%
Cap/Depr(5y)69.7%
Cap/Sales(3y)3.99%
Cap/Sales(5y)3.41%
Profit Quality(3y)98.91%
Profit Quality(5y)102.51%
High Growth Momentum
Growth
EPS 1Y (TTM)9.79%
EPS 3Y15.77%
EPS 5Y16.84%
EPS Q2Q%9.73%
EPS Next Y12.75%
EPS Next 2Y11.88%
EPS Next 3Y11.47%
EPS Next 5Y11.23%
Revenue 1Y (TTM)7.75%
Revenue growth 3Y9.6%
Revenue growth 5Y7.85%
Sales Q2Q%8.9%
Revenue Next Year8.99%
Revenue Next 2Y8.25%
Revenue Next 3Y8.38%
Revenue Next 5Y7.52%
EBIT growth 1Y11.71%
EBIT growth 3Y13.89%
EBIT growth 5Y14.4%
EBIT Next Year31.87%
EBIT Next 3Y15.86%
EBIT Next 5Y12.75%
FCF growth 1Y35.78%
FCF growth 3Y10.65%
FCF growth 5Y10.61%
OCF growth 1Y29.87%
OCF growth 3Y12.1%
OCF growth 5Y10.89%

CINTAS CORP / CTAS Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for CINTAS CORP?

ChartMill assigns a fundamental rating of 7 / 10 to CTAS.


What is the valuation status for CTAS stock?

ChartMill assigns a valuation rating of 2 / 10 to CINTAS CORP (CTAS). This can be considered as Overvalued.


How profitable is CINTAS CORP (CTAS) stock?

CINTAS CORP (CTAS) has a profitability rating of 10 / 10.


Can you provide the financial health for CTAS stock?

The financial health rating of CINTAS CORP (CTAS) is 8 / 10.


Can you provide the expected EPS growth for CTAS stock?

The Earnings per Share (EPS) of CINTAS CORP (CTAS) is expected to grow by 12.75% in the next year.